Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 15, 2024

BUY
$48.64 - $57.81 $384,791 - $457,334
7,911 New
7,911 $457,000
Q3 2023

Oct 26, 2023

BUY
$50.19 - $54.68 $5,019 - $5,468
100 Added 1.28%
7,911 $417,000
Q4 2022

Feb 14, 2023

SELL
$39.56 - $47.22 $229,448 - $273,876
-5,800 Reduced 42.61%
7,811 $361,000
Q2 2022

Aug 15, 2022

BUY
$35.24 - $47.1 $140,960 - $188,400
4,000 Added 41.62%
13,611 $507,000
Q4 2021

Feb 15, 2022

SELL
$38.07 - $44.87 $68,526 - $80,766
-1,800 Reduced 15.77%
9,611 $408,000
Q1 2018

May 14, 2018

BUY
$25.2 - $28.54 $287,557 - $325,669
11,411 New
11,411 $312,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $144B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Punch & Associates Investment Management, Inc. Portfolio

Follow Punch & Associates Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Punch & Associates Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Punch & Associates Investment Management, Inc. with notifications on news.